Skip to main content
. Author manuscript; available in PMC: 2021 Jul 28.
Published in final edited form as: Clin Colorectal Cancer. 2019 Jul 2;18(3):192–199.e1. doi: 10.1016/j.clcc.2019.06.006

Fig 5.

Fig 5.

Spider plots of individual tumor sizes per treatment group from a representative tumor experiment. A. Control group treated with PBS. B. Mice treated with 0.3 mg/kg Actinomycin D. C. Mice treated with 2.5 mg/kg LMB-100 and D. Mice treated with 0.3 mg/kg Actinomycin D and 2.5 mg/kg LMB-100. Combination treated group was noted to have 50% CR rate with a significant delay in tumor regrowth to 300 mm3 following initial two cycles of therapy.